PROPEL Contour receives CE mark. Click here to learn more.
Fiagon AG Medical Technologies is now part of Intersect ENT – Click here to learn more about our navigation offering.

Resources for Patients, Physicians and Practices

Overview
Case Studies
Clinical Evidence
Practice Resources
Reimbursement
Patient Education

Real world examples of usage of the PROPEL steroid-releasing implants to improve sinus surgery outcomes and reduce the need for revision surgery.1,2

video thumbnail

The Iceberg Effect in Chronic Sinusitis

A case-study based discussion led by Dr. David Conley and Dr. Samer Fakhri, highlighting the options for management of inflammation in CRS.

Watch the Video

Video thumbnail

Preserving Frontal Sinus Patency

Dr. Ameet Singh and Dr. Roheen Raithatha lead a case study-based discussion on the latest clinical evidence to maintaining frontal sinus patency.

Watch the Video

Video thumbnail

Ethmoid Sinus Surgery with PROPEL implants

Video case study highlighting 4-month outcomes following ethmoid sinus surgery in revision surgery patient.

Watch the Video

Video thumbnail

Frontal Sinus Surgery with PROPEL Mini Implants

Case study comparing outcomes of frontal sinus surgery with PROPEL Mini sinus implant versus surgery alone. See the 30-day and 1 year outcomes.

Watch the Video

Video thumbnail

PROPEL Mini placement in Frontal & Ethmoid Sinus

An example of placement technique for deploying PROPEL Mini implant in frontal and ethmoid sinus.

Watch the Video

The PROPEL sinus implants are indicated to maintain patency and locally deliver steroid to the sinus mucosa in patients ≥18 years of age after sinus surgery: PROPEL for the ethmoid sinus, PROPEL Mini for the ethmoid sinus/frontal sinus opening, and PROPEL Contour for the frontal/maxillary sinus ostia. Contraindications include patients with intolerance to mometasone furoate (MF) or hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implant in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of the implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. Rx only.


1 Kennedy DW, Wright ED, Goldberg AN. Laryngoscope. 2000; 110(S94):29-31.
2 Kennedy DW. Expert Review of Respiratory Medicine. 2012; 6(5):493-498.

More Intersect ENT Resources

Access in-depth product and device prep guides, intra-op and post-op best practices, forms, programs, videos, and more content developed for physicians.

Physician Resource Center
logo

Contact Us | Privacy Policy | Terms and Conditions | 1555 Adams Drive | Menlo Park, CA 94025 | 650.641.2100

©2021 Intersect ENT, Inc. All rights reserved. MPM-10679 Rev 15.0 INTERSECT ENT and PROPEL are registered trademarks of Intersect ENT, Inc. in the United States and other countries.